Optimization of a Human Anti-polio Monoclonal Antibody as a Potential Therapeutic Modality
Shwu‐Maan Lee, Christine C. Siska, Igor D’Angelo, Diana V. Kouiavskaia, Kutub Mahmood
This paper optimizes a human monoclonal antibody against poliovirus to improve its serum half-life and manufacturability through sequence engineering and experimental evaluation.
bioRxiv · Sep 22, 2026 · PreprintBiochemistry